PHARMACOECONOMIC ISSUES OF ADALIMUMAB THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS

QR Code

PHARMACOECONOMIC ISSUES OF ADALIMUMAB THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS

Background. Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children and is associated with reduced quality of life and increased health care costs. Objective. To evaluate the cost effectiveness of the tumour necrosis factor inhibitor adalimumab (ADA) vs. non-biologic the...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. Simpson, N. Marlow, J. Shaw, А. V. Rudakova
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2012-08-01
Series:	Педиатрическая фармакология
Subjects:	juvenile idiopathic arthritis adalimumab cost-effectiveness analysis
Online Access:	https://www.pedpharma.ru/jour/article/view/302
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-12-01)

EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: K. B. Isaeva, et al.
Published: (2014-07-01)

EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α — ADALIMUMAB — IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

The Efficiency of Adalimumab in Cases of Chronic Methotrexate-Resistant Juvenile Idiopathic Arthritis-Associated Anterior Uveitis: Retrospective Case Series Study
by: E. V. Gaidar, et al.
Published: (2016-11-01)

EFFICACY OF USE OF TNF INHIBITOR ADALIMUMAB IN A FEMALE PATIENT WITH CHRONIC UVEITIS IN THE ONSET OF JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Pavkhun, et al.
Published: (2016-02-01)

EFFICACY AND SAFETY OF PEDIATRIC JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS TREATMENT WITH ADALIMUMAB
by: E. I. Alexeeva, et al.
Published: (2012-01-01)

ADALIMUMAB USAGE CASE IN A PATIENT WITH JUVENILE OLIGOARTHRITIS AND UVEITIS
by: L. A. Balykova, et al.
Published: (2013-11-01)

The Efficacy of Combination Therapy by Adalimumab with Methotrexate and of Monotherapy by Methotrexate for Children Suffering from Polyarticular Juvenile Idiopathic Arthritis
by: V. A. Keltsev, et al.
Published: (2016-01-01)

Retrospective Cohort Study of Effectiveness and Safety of Adalimumab Use in Children with Juvenile Idiopathic Arthritis in the Republic of Bashkortostan
by: V. A. Maliyevskiy, et al.
Published: (2016-02-01)

Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations
by: E. I. Alexeeva, et al.
Published: (2015-09-01)

EFFECTIVE USE OF MONOCLONAL ANTIBODIES AGAINST TNF — ADALIMUMAB — AS A SWITCHOVER DRUG IN A PATIENT WITH JUVENILE IDIOPATHIC POLYARTHRITIS AND UVEITIS
by: S. A. Ushakova, et al.
Published: (2014-11-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF TREATMENT USING ADALIMUMAB IN COMBINATION WITH METHOTREXATE AND METHOTREXATE MONOTHERAPY IN CHILDREN WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS IN COMBINATION WITH UVEITIS
by: V. А. Kel’tsev, et al.
Published: (2014-12-01)

EFFICACY OF ADALIMUMAB IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: L. A. Galstyan, et al.
Published: (2012-11-01)

The Experience of Successful Use of Adalimumab in a Patient With Juvenile Arthritis Associated With Enthesitis and Uveitis
by: Aleksandra M. Chomakhidze, et al.
Published: (2017-10-01)

Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study
by: Ekaterina I. Alexeeva, et al.
Published: (2018-12-01)

Experience of use of the anti-cytokine drug adalimumab in children with polyarticular seronegative junior arthritis living in the Samara region
by: S. V. Plakhotnikova, et al.
Published: (2023-10-01)

RESULTS OF RETROSPECTIVE OBSERVATIONAL STUDY OF ADALIMUMAB SAFETY AND EFFICACY IN PATIENTS WITH JUVENILE ARTHRITIS AND UVEITIS
by: Е.I. Alexeeva, et al.
Published: (2011-11-01)

A HISTORY CASE OF ADALIMUMAB TREATMENT IN A FEMALE PATIENT WITH JUVENILE ARTHRITIS AND UVEITIS AS MANIFESTATIONS OF CROHN’S DISEASE
by: V. A. Malievskii, et al.
Published: (2013-07-01)

Methotrexate in the combination therapy of juvenile idiopathic arthritis
by: E. S. Zholobova, et al.
Published: (2018-09-01)

EXPERIENCE WITH ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Margarita Fedorovna Dubko, et al.
Published: (2012-10-01)

Causes of invalidity in patients with juvenile idiopathic arthritis
by: T A Slielepina
Published: (2005-04-01)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
by: E. I. Alekseeva, et al.
Published: (2016-11-01)

POSSIBLE PARENTERAL METHOTREXATE APPLICATION IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Yu. М. Spivakovsky, et al.
Published: (2014-12-01)

Differences of hip involvement in systemic and non-systemic juvenile idiopathic arthritis
by: L. S. Sorokina, et al.
Published: (2022-03-01)

Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)

ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: INTERNATIONAL DATA AND EXPERIENCE OF USAGE IN THE REPUBLIC OF MORDOVIA
by: L. A. Balykova, et al.
Published: (2014-03-01)

Analysis of the Juvenile Idiopathic Arthritis Immunization Schedule
by: L. S. Namazova-Baranova, et al.
Published: (2016-11-01)

Review of International Registers of Patients with Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alekseeva, et al.
Published: (2017-04-01)

Efficacy of Abatacept Therapy in a Patient with Juvenile Idiopathic Arthritis and Bilateral Uveitis
by: Lelia A. Galstian, et al.
Published: (2016-08-01)

Efficacy of rehabilitation therapy on hospital stage of treatment of patients with juvenile idiopathic arthritis
by: T A Shelepina, et al.
Published: (2008-06-01)

EFFICACY AND SAFETY OF ANTI-TNFα HUMAN MONOCLONAL ANTIBODIES IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND SECONDARY RESISTANCE TO OTHER GENETICALLY ENGINEERED BIOLOGICAL AGENTS
by: E. I. Alexeeva, et al.
Published: (2012-07-01)

MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF JUVENILE IDIOPATHIC ARTHRITIS
by: A. K. Traudt, et al.
Published: (2015-02-01)

THE PHENOMENON OF NEUTROPENIA DURING TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: M. I. Kaleda, et al.
Published: (2018-01-01)

EXPERIENCE OF RITUXIMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alekseeva, et al.
Published: (2012-08-01)

Principles on the use of imaging studies in the diagnosis and management of juvenile idiopathic arthritis
by: N. T. Vatutin, et al.
Published: (2016-01-01)

EXPERIENCE OF TREATMENT OF THE TWINS SICK WITH JUVENILE IDIOPATHIC ARTHRITIS BY ABATACEPT
by: V. A. Kel'tsev
Published: (2014-05-01)

Juvenile idiopathic arthritis outcome and prognosis according to catamnesis evaluation
by: O V Semenova, et al.
Published: (2005-10-01)

THE STRUCTURE AND CLINICAL MANIFESTATIONS OF JUVENILE IDIOPATHIC ARTHRITIS IN CHILDREN IN KRASNODAR
by: A. V. Burlutskaya, et al.
Published: (2018-12-01)

EXPERIENCE OF ABATACEPT TREATMENT IN A PATIENT WITH ANTIBODY-POSITIVE IDIOPATHIC JUVENILE ARTHRITIS
by: T. M. Bzarova, et al.
Published: (2012-03-01)

CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-09-01)